<DOC>
	<DOCNO>NCT00574210</DOCNO>
	<brief_summary>The purpose study evaluate relative efficacy four dosing regimen bilastine tablet versus placebo subject SAR expose control ragweed pollen use EEC model base mean change baseline Total Nasal Symptom Scores ( TNSS ) . Study include male female subject , age 18 65 year clinical history SAR seasonal onset offset nasal allergy symptom last two ragweed allergy season positive skin prick test ragweed allergen within 12 month prior randomization .</brief_summary>
	<brief_title>PK/PD Steady State Efficacy Study Bilastine Compared With Placebo Given Orally Treatment Symptoms SAR EEC Model ( 5-Arm )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Clinical history SAR last two ragweed allergy season . A positive skin test within 12 month screen ragweed allergen . A minimum qualifying symptom score Visits , 2 3 . Females must confirm absence pregnancy accord negative urine pregnancy test . Women pregnant , breastfeeding , plan pregnancy . History mild asthma . History clinically significant ( determined Investigator ) active perennial allergic rhinitis subject regularly expose . Nonallergic rhinitis ( vasomotor rhinitis medicamentosa ) . An anatomic abnormality interfere assessment nasal function . History clinically significant recurrent sinusitis chronic sinusitis . Clinically significant ( determined Investigator ) cardiovascular , hepatic , neurologic , psychiatric , endocrine , significant systemic disease make implementation protocol jeopardize safety subject . A need use antihistamine corticosteroid regular basis ( systemic topical ) . Currently take monoamine oxidase ( MAO ) inhibitor . Taken systemic corticosteroid , immunomodulators , immune suppressive medication within four week prior Visit 1 . Taken antihistamine within seven day prior Visit 1 skin testing . Known current alcohol drug abuse . Current participation another clinical study involve experimental treatment , participation study within 30 day prior study entry . History generalize anaphylaxis require medical attention . Clinically significant abnormality screen blood chemistry , hematology , urinalysis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Seasonal Allergic Rhinitis ( SAR )</keyword>
	<keyword>Environmental Exposure Chamber ( EEC )</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Antihistamine Drug</keyword>
	<keyword>Ragweed Pollen</keyword>
</DOC>